Lost in fibrosis
Nature Communications
March 14, 2012
The loss of inhibitory proteins in a type of cell known as fibroblasts is associated with fibrotic diseases, reports a paper published in Nature Communications this week. The finding could eventually prove useful in the development of specific treatments for fibrosis. In fibrotic diseases, such as pulmonary fibrosis or liver cirrhosis, an overproduction of springy molecules, like collagen, by fibroblasts can disrupt the function of tissues and organs. The molecular mechanisms leading to the unusual activation of fibroblasts are incompletely understood, which has hindered the development of anti-fibrotic therapies. Studying skin sections from patients with various fibrotic diseases, Jorg Distler and his team found that the protein Dickkopf-1 was missing in fibroblasts in fibrotic skin. They noted that mice that produced Dickkopf-1 continuously were protected from fibrosis in various experimental models of the disease. The group show that loss of Dickkopf-1 is caused by a growth factor that is known to be involved in fibrosis, and that Dickkopf-1 normally inhibits the signalling molecule Wnt. The findings suggest that inhibition of Wnt signalling by Dickkopf-1 or specific drugs might be an effective treatment of fibrotic diseases.
doi: 10.1038/ncomms1734
Research highlights
-
Aug 12
Ageing: Mutations in the ageing human heart identifiedNature Aging
-
Aug 12
Palaeontology: T. rex and relatives traded big eyes for bigger bitesCommunications Biology
-
Aug 10
Epidemiology: Estimating the risk of SARS-related coronaviruses from bats in Southeast AsiaNature Communications
-
Aug 5
Microbiology: Single switch makes Escherichia coli beneficial insect partnerNature Microbiology
-
Aug 5
Conservation: More than half of unassessable species may be at risk of extinctionCommunications Biology
-
Aug 4
Physiology: Restoring cellular functions in pigs after deathNature